4//SEC Filing
Long Alison S 4
Accession 0001209191-22-003532
CIK 0001751299other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 5:15 PM ET
Size
7.9 KB
Accession
0001209191-22-003532
Insider Transaction Report
Form 4
Long Alison S
Chief Medical Officer
Transactions
- Award
Restricted Stock Units
2022-01-14+46,800→ 46,800 total→ Common Stock (46,800 underlying) - Award
Restricted Stock Units
2022-01-14+125,000→ 125,000 total→ Common Stock (125,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
- [F2]The restricted stock units shall vest 100% on April 30, 2022 provided, however, that the grant shall immediately vest as of the date of any change in control of the issuer.
- [F3]The restricted stock units shall vest on the earlier of 50% on January 14, 2023 and 50% on January 14, 2024 provided, however, that the grant shall immediately vest as of the date of any change in control of the issuer.
Documents
Issuer
Kaleido Biosciences, Inc.
CIK 0001751299
Entity typeother
Related Parties
1- filerCIK 0001891712
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 5:15 PM ET
- Size
- 7.9 KB